Jilin Aodong Pharmaceutical Group Co., Ltd.

Total Valuation

Jilin Aodong Pharmaceutical Group Co., Ltd. carries a market capitalization of 21.60B, placing it among publicly traded companies globally. Its enterprise value stands at 19.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Jilin Aodong Pharmaceutical Group Co., Ltd. currently has 1.20B shares outstanding.

Valuation Ratios

Jilin Aodong Pharmaceutical Group Co., Ltd. trades at a trailing price-to-earnings ratio of 8.68. The price-to-sales ratio is 8.57, and the price-to-book ratio stands at 0.91.

Enterprise Valuation

Financial Position

Jilin Aodong Pharmaceutical Group Co., Ltd. maintains a current ratio of 2.02, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.49, indicating elevated leverage, while an interest coverage ratio of -1.68 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Jilin Aodong Pharmaceutical Group Co., Ltd. posts a return on equity of 10.85 and a return on invested capital of -0.26.

Taxes

Over the trailing twelve months, Jilin Aodong Pharmaceutical Group Co., Ltd. has paid 108.12M in income taxes, reflecting an effective tax rate of 4.53.

Stock Price Statistics

Jilin Aodong Pharmaceutical Group Co., Ltd.'s stock has gained approximately 5.42907% over the past 52 weeks. The 50-day moving average sits at 17.93, while the 200-day moving average is 19.05.

Income Statement

Over the trailing twelve months, Jilin Aodong Pharmaceutical Group Co., Ltd. generated 2.33B in revenue and converted that into 2.30B in net income, yielding earnings per share of 1.94. EBITDA reached -87.48M, while operating income came in at -87.48M.

Balance Sheet

Jilin Aodong Pharmaceutical Group Co., Ltd. holds 3.20B in cash and equivalents against 2.26B in total debt, resulting in a net debt position of 721.72M. Total book value stands at 21.91B, with working capital of 2.66B providing operational flexibility.

Cash Flow

After subtracting -152.48M in capital expenditures, free cash flow totaled -152.48M - equivalent to -0.13 per share.

Margins

Jilin Aodong Pharmaceutical Group Co., Ltd. operates with a gross margin of 45.75, reflecting its pricing power and cost economics. The operating margin of -3.76 and net profit margin of 98.72 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 45.18 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Jilin Aodong Pharmaceutical Group Co., Ltd.'s most recent stock split took place on June 19, 2017 with a 10:13 split ratio.

Scores

Jilin Aodong Pharmaceutical Group Co., Ltd. posts an Altman Z-Score of 4.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.